Nora Mahoney, PA
Physician Assistant · Amherst, MANPI 1558996975
Payments from drug & device makers
Across 119 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$312
- Amgen$280
- Pfizer$277
- Actelion Pharmaceuticals US, Inc.$227
- Johnson & Johnson$224
- Boehringer Ingelheim$213
- plus $888 from 19 others
What the payments were for
- Food & beverage$2,33396%
- Education$894%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $312 |
| Amgen | 15 | $280 |
| Pfizer | 15 | $277 |
| Actelion Pharmaceuticals US, Inc. | 7 | $227 |
| Johnson & Johnson | 13 | $224 |
| Boehringer Ingelheim | 10 | $213 |
| Bridgebio Pharma, Inc. | 8 | $191 |
| Harmony Biosciences LLC | 5 | $134 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $112 |
| Novartis | 5 | $85 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Novo Nordisk | 2 | $38 |
| GSK | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Edwards Lifesciences | 1 | $26 |
| Altathera Pharmaceuticals LLC | 2 | $25 |
| Abbott | 1 | $23 |
| Bayer | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $17 |
| United Therapeutics Corporation | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
How this compares
$2,422 in reported general payments places this provider in the 90th percentile of 3,507 physician assistant providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 18 | $478 |
| Atorvastatin Calcium | 21 | $452 |
| Rosuvastatin Calcium | 12 | $333 |
| Lisinopril | 31 | $265 |
| Metformin Hcl | 11 | $190 |
| Simvastatin | 14 | $162 |
| Losartan Potassium | 14 | $142 |
| Levothyroxine Sodium | 14 | $126 |
| Amlodipine Besylate | 12 | $68 |
| Hydrochlorothiazide | 16 | $32 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Amherst
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Stacey PanasciSpringfield$113K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
- David PeckhamQuincy$61K
- Leslie SmithSpringfield$49K
- Andrea MilliganBoston$46K
- Lauren RousseauBoston$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.